Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells

Kidney International

Volumn 66, Issue 6, 2004, Pages 2329-2336

  Ni, Zhenmin ^a   Hou, Stephen ^a   Barton, Cyril H ^a   Vaziri, Nosratola D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Hydrogen peroxide; Hypertension; Lead; Nitric oxide; Oxidative stress; Superoxide

Indexed keywords

ACETIC ACID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; HYDROETHIDINE; HYDROGEN PEROXIDE; LEAD ACETATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; CYBB PROTEIN, HUMAN; LEAD; MEMBRANE PROTEIN; SUPEROXIDE DISMUTASE;

ARTICLE; CELL POPULATION; COMPUTER PROGRAM; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; PATHOGENESIS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; CELL CULTURE; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; METABOLISM; OXIDATIVE STRESS; VASCULAR ENDOTHELIUM;

CATALASE; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; LEAD; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 21644466520     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.66032.x     Document Type: Article

References (22)

1. VAZIRI ND: Pathogenesis of lead-induced hypertension: Role of oxidative stress. J Hypertension 20:S15-20, 2002
2. VAZIRI ND, DING Y, NI Z, et al: Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy. Kidney Int 52:1042-1046, 1997
3. GONICK HC, DING Y, BONDY SC, et al: lead-induced hypertension: Interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487-1492, 1997
4. VAZIRI ND, DING Y, NI Z: Nitric oxide synthase expression in the course of lead induced hypertension. Hypertension 34:558-562, 1999
5. VAZIRI ND, LIANG K, DING Y: Increased nitric oxide inactivatton by reactive oxygen species in lead-induced hypertension. Kidney Int 56:1492-1498, 1999
6. VAZIRI ND, DING Y, NI Z: Compensatory upregulation of NO synthase isoforms in lead-induced hypertension: Reversal by a SOD-mimetic drug. J Pharmacol Exp Ther 298: 679-685, 2001
7. SHARP DS, OSTERLOH J, BECKER CE, et al: Blood pressure and blood lead concentration in bus drivers. Environ Health Perspect 78:131-137, 1988
8. HARLAN WR: The relationship of blood lead levels to blood pressure in the U.S. population. Environ health Perspect 78:9-13, 1988
9. KHLIL-MENESH F, GONICK HC, WEILER EW, et al: Effect of chelating treatment with dimercaptosuccinic acid (DMSA) on lead-related blood pressure changes. Environs Res 65:86-99, 1994
10. DING Y, GONICK HC, VAZIRI ND: Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypertension 13:552-555, 2000
11. DING Y, GONICK HC, VAZIRI ND, et al: Lead-induced hypertension: Increased hydroxyl radical production. Am J Hypertension 14:169-173, 2001
12. DING Y, VAZIRI ND, GONICK HC: Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide simutase, and nitroprusside. Environ Res 76:107-113, 1998
13. VAZIRI ND, DING Y: Effect of lead on NO synthase expression in coronary endothelial cells: Role of superoxide. Hypertension 37:223-226, 2001
14. VAZIRI ND, LIN CY, DING Y, SINDHU RK: Superoxide dismutase, catalase, glutathione peroxidase and NAD(P)H oxidase in lead-induced hypertension. Kidney Int 63:186-194, 2003
15. MALVEZZI CK, MOREIRA EG, VASSILIEFF I: Effect of L-arginine, dimercaptosuccinic acid (DMSA) and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism. Braz J Med Biol Res 34:1341-1346, 2001
16. CORY-SLECHTA DA: Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy. J Pharmacol Exp Ther 246:84-91, 1988
17. VAZIRI ND, DICUS M, HO ND, et al: Oxidative stress and dysregulation of superoxide dismutase and NAD(P)H oxidase in renal insufficiency. Kidney Int 63:179-185, 2003
18. LIM CS, VAZIRI ND: The effects of iron dextran on oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int 65:1802-1809, 2004
19. SOKAS RK, SIMMENS S, SOPHAR K, et al: Lead level in Maryland construction workers. Am J Ind Med 31:188-194, 1997
20. VAZIRI ND: Role of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hyptens 13:93-98, 2004
21. RODRIGUEZ-ITRUBE B, VAZIRI ND, HERRERA-ACOSTA J, JOHNSON R: Oxidative stress, renal infiltration of immune cells and salt sensitive hypertension: All for one and one for all. Am J Physiol, Renal Physiol 286:F606-F616, 2004
22. GRIENDLING KK, SORESCU D, USHIO-FUKAI M: NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86:494-501, 2000